CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Apr 14, 2025. (Total: 6636 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-11 (of 11 Records)

Query Trace: Metchock B[original query]
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates. Kaniga K , Hasan R , Jou R , Vasiliauskienė E , Chuchottaworn C , Ismail N , Metchock B , Miliauskas S , Viet Nhung N , Rodrigues C , Shin S , Simsek H , Smithtikarn S , Ngoc ALT , Boonyasopun J , Kazi M , Kim S , Kamolwat P , Musteikiene G , Sacopon CA , Tahseen S , Vasiliauskaitė L , Wu MH , Vally Omar S . J Clin Microbiol 2021 60 (1) Jcm0291920
Towards Unified Data Exchange Formats for Reporting Molecular Drug Susceptibility Testing. Bonney W , Price SF , Abhyankar S , Merrick R , Hampole V , Halse TA , DiDonato C , Dalton T , Metchock B , Starks AM , Miramontes R . Online J Public Health Inform 2020 12 (2) e14
Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests. Kandler JL , Mercante AD , Dalton TL , Ezewudo MN , Cowan LS , Burns SP , Metchock B , Cegielski P , Posey JE . Antimicrob Agents Chemother 2018 62 (10)
Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States. Yakrus MA , Driscoll J , McAlister A , Sikes D , Hartline D , Metchock B , Starks AM . Tuberc Res Treat 2016 2016 3404860
Evaluation of Xpert MTB/RIF to identify pulmonary tuberculosis in tuberculosis suspects from low and higher prevalence settings compared to acid fast smear and culture Firnhaber C , Kendall MA , Wu X , Mazurek GH , Benator DA , Arduino R , Fernandez M , Guy E , Johnson P , Metchock B , Sattler F , Telzak E , Wang YF , Weiner M , Swindells S , Sanne IM , Havlir DV , Grinsztejn B , Alland D . Clin Infect Dis 2016 62 (9) 1081-8
Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosis. Yakrus MA , Metchock B , Starks AM . Tuberc Res Treat 2015 2015 701786
DNA sequencing for confirmation of rifampin resistance detected by Cepheid Xpert MTB/RIF assay. McAlister AJ , Driscoll J , Metchock B . J Clin Microbiol 2015 53 (5) 1752-3
Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States. Yakrus MA , Driscoll J , Lentz AJ , Sikes D , Hartline D , Metchock B , Starks AM . J Clin Microbiol 2014 52 (6) 1932-7
Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing Kalokhe AS , Shafiq M , Lee JC , Ray SM , Wang YF , Metchock B , Anderson AM , Nguyen MLT . Am J Med Sci 2012 345 (2) 143-8
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs Kurbatova EV , Cavanaugh JS , Shah NS , Wright A , Kim H , Metchock B , Van Deun A , Barrera L , Boulahbal F , Richter E , Martin-Casabona N , Arias F , Zemanova I , Drobniewski F , Santos Silva A , Coulter C , Lumb R , Cegielski JP . Int J Tuberc Lung Dis 2012 16 (3) 355-357
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Campbell PJ , Morlock GP , Sikes RD , Dalton TL , Metchock B , Starks AM , Hooks DP , Cowan LS , Plikaytis BB , Posey JE . Antimicrob Agents Chemother 2011 55 (5) 2032-41